Content about Bristol-Myers Squibb

February 17, 2011

The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.

February 14, 2011

An investigational drug made by Bristol-Myers Squibb works better than aspirin in reducing the risk of complications in certain patients with heart rhythm problems, according to results of a late-stage clinical trial published in the New England Journal of Medicine.

January 7, 2011

A new oral treatment for Type 2 diabetes hit the shelves Friday.

December 21, 2010

Bristol-Myers Squibb has signed a definitive licensing pact with Oncolys BioPharma, a privately held Japanese biotech company, that will give it control of a promising new HIV treatment.

December 8, 2010

Chemotherapy drugs made by Johnson & Johnson and Merck will become the standard second-line treatment for ovarian cancer within the decade, replacing a treatment made by Bristol-Myers Squibb and generic versions, according to a new report by market research firm Decision Resources.

December 7, 2010

The Food and Drug Administration has accepted for review a supplemental approval application for an arthritis drug made by Bristol-Myers Squibb, the drug maker said Monday.

November 15, 2010

The U.S. District Court for the District of Delaware has upheld a patent held by...

November 14, 2010

Look for a big surge in brand-to-generic drug switches at the pharmacy counter over the...

November 10, 2010

A drug maker's philanthropic arm announced its commitment to fight Type 2 diabetes in the...

November 7, 2010

The Food and Drug Administration approved the first and only once-a-day metformin extended-release plus dipeptidyl...

November 7, 2010

Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a...

October 27, 2010

The Food and Drug Administration has approved a new usage for a blood cancer drug,...

October 4, 2010

The Food and Drug Administration has approved a generic drug for HIV made by a...

September 27, 2010

The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...

September 23, 2010

An investigational diabetes drug works as well as a generic already on the market, according...

September 21, 2010

Abbott on Wednesday initiated a proactive, voluntary recall of certain Similac powder infant formulas in...

September 12, 2010

An investigational treatment for HIV by Gilead Sciences that combines four drugs in one tablet...

September 9, 2010

Bristol-Myers Squibb formally has begun its tender offer for biotech company ZymoGenetics, the drug maker...

September 7, 2010

Bristol-Myers Squibb will acquire Seattle-based biotech ZymoGenetics, Bristol said Wednesday....

August 17, 2010

The Food and Drug Administration has agreed to expedite review of an investigational treatment for...

August 10, 2010

The drug market for unipolar depression will get smaller over the next decade due to...

July 21, 2010

An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...

June 21, 2010

Cases of the potentially deadly skin cancer melanoma are expected to almost double before the...

June 6, 2010

An investigational drug for skin cancer that had spread to other parts of the body...

© 2014 Drug Store News. All Rights Reserved.